Dinutuximab

WikiDoc Resources for Dinutuximab
Articles
Most recent articles on Dinutuximab Most cited articles on Dinutuximab Review articles on Dinutuximab Articles on Dinutuximab in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dinutuximab Images of Dinutuximab Photos of Dinutuximab Podcasts & MP3s on Dinutuximab Videos on Dinutuximab
Evidence Based Medicine
Cochrane Collaboration on Dinutuximab Bandolier on Dinutuximab TRIP on Dinutuximab
Clinical Trials
Ongoing Trials on Dinutuximab at Clinical Trials.gov Trial results on Dinutuximab Clinical Trials on Dinutuximab at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dinutuximab NICE Guidance on Dinutuximab NHS PRODIGY Guidance FDA on Dinutuximab CDC on Dinutuximab
Books
Books on Dinutuximab
News
Dinutuximab in the news Be alerted to news on Dinutuximab News trends on Dinutuximab
Commentary
Blogs on Dinutuximab
Definitions
Definitions of Dinutuximab
Patient Resources / Community
Patient resources on Dinutuximab Discussion groups on Dinutuximab Patient Handouts on Dinutuximab Directions to Hospitals Treating Dinutuximab Risk calculators and risk factors for Dinutuximab
Healthcare Provider Resources
Symptoms of Dinutuximab Causes & Risk Factors for Dinutuximab Diagnostic studies for Dinutuximab Treatment of Dinutuximab
Continuing Medical Education (CME)
CME Programs on Dinutuximab
International
Dinutuximab en Espanol Dinutuximab en Francais
Business
Dinutuximab in the Marketplace Patents on Dinutuximab
Experimental / Informatics
List of terms related to Dinutuximab

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dinutuximab (tradename Unituxin) is a drug developed by United Therapeutics for the treatment of high-risk neuroblastoma in pediatric patients. It was approved for use by the United States Food and Drug Administration for use on March 10, 2015.